Annual EBITDA
$45.99M$62.66M-57.67%
Summary
- Current Value
- As of today, PEN annual EBITDA is $45.99M, down -57.67% on
- Historical Performance
- PEN annual EBITDA is up +486.67% over the past 3 years, and down -17.30% over the past 5 years
- All-Time High Comparison
- PEN annual EBITDA is currently -57.67% below its historical high of $108.65M set on
- 3-Year Low Comparison
- PEN annual EBITDA is +53.49% above its 3-year low of $29.96M reached on an earlier date
- Sector Comparison
- PEN annual EBITDA is higher than 83.63% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $45.99M | -57.7% | +486.7% | -17.3% | +1241.6% | |
| Quarterly EBITDA | $51.33M | +29.9% | +340.2% | +405.2% | +2463.7% | |
| TTM EBITDA | $193.73M | +79.1% | +1376.6% | +1657.7% | +9576.7% | |
| Price | $316.15 | +25.3% | +37.2% | +61.9% | – | |
| PE Ratio | 75.55 | -89.7% | – | – | – | |
| Annual Revenue | $1.19B | +12.9% | +59.8% | +118.2% | +1533.3% | |
| Annual EPS | $0.36 | -84.6% | +155.8% | -73.3% | +346.6% | |
| Annual EBIT | $22.29M | -72.6% | +360.1% | -53.1% | +550.1% | |
| Annual Net Income | $14.01M | -84.6% | +434.2% | -70.2% | +615.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $108.65M | -57.7% | |
| 5Y | $108.65M | -57.7% | |
| All | $108.65M | -57.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $29.96M | N/A | +53.5% |
| 5Y | -$26.05M | N/A | +276.5% |
| All | -$26.05M | +276.5% |
EBITDA History
FAQ
What is the current annual EBITDA of PEN?
As of today, PEN annual EBITDA is $45.99M
What is 1-year change in PEN annual EBITDA?
PEN annual EBITDA is down -57.67% year-over-year
What is 3-year change in PEN annual EBITDA?
PEN annual EBITDA is up +486.67% over the past 3 years
How far is PEN annual EBITDA from its all-time high?
PEN annual EBITDA is currently -57.67% below its historical high of $108.65M set on December 31, 2023
How does PEN annual EBITDA rank versus sector peers?
PEN annual EBITDA is higher than 83.63% of companies in Healthcare sector
When is PEN next annual earnings release?
The next annual earnings release for PEN is on
Quarterly EBITDA
$51.33M$4.99M+10.77%
Summary
- Current Value
- As of today, PEN quarterly EBITDA is $51.33M, up +10.77% on
- Historical Performance
- PEN quarterly EBITDA is up +29.90% year-over-year, and up +340.23% over the past 3 years
- All-Time High Comparison
- PEN quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- PEN quarterly EBITDA is +1313.55% above its 3-year low of $3.63M reached on
- Sector Comparison
- PEN quarterly EBITDA is higher than 85.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $51.33M | +10.8% | +29.9% | +340.2% | +405.2% | |
| Annual EBITDA | $45.99M | – | -57.7% | +486.7% | -17.3% | |
| TTM EBITDA | $193.73M | +6.5% | +79.1% | +1376.6% | +1657.7% | |
| Price | $316.15 | +26.9% | +25.3% | +37.2% | +61.9% | |
| PE Ratio | 75.55 | +26.9% | -89.7% | – | – | |
| Quarterly Revenue | $354.69M | +4.5% | +17.8% | +66.0% | +134.8% | |
| Quarterly EPS | $1.17 | +1.1% | +54.8% | +2047.6% | +579.1% | |
| Quarterly EBIT | $48.84M | +19.6% | +38.1% | +798.8% | +342.3% | |
| Quarterly Net Income | $45.85M | +1.3% | +55.3% | +2119.0% | +564.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $51.33M | at high | |
| 3Y | $51.33M | at high | |
| 5Y | $51.33M | at high | |
| All | $51.33M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $45.37M | +13.1% | |
| 3Y | $3.63M | +1313.5% | |
| 5Y | -$34.30M | +249.6% | |
| All | -$34.30M | +249.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of PEN?
As of today, PEN quarterly EBITDA is $51.33M
What is PEN quarterly EBITDA most recent change?
PEN quarterly EBITDA was up +10.77% on September 30, 2025
What is 1-year change in PEN quarterly EBITDA?
PEN quarterly EBITDA is up +29.90% year-over-year
How far is PEN quarterly EBITDA from its all-time high?
PEN quarterly EBITDA is currently at its all-time high
How does PEN quarterly EBITDA rank versus sector peers?
PEN quarterly EBITDA is higher than 85.91% of companies in Healthcare sector
When is PEN next earnings release?
The next earnings release for PEN is on
TTM EBITDA
$193.73M$11.81M+6.49%
Summary
- Current Value
- As of today, PEN TTM EBITDA is $193.73M, up +6.49% on
- Historical Performance
- PEN TTM EBITDA is up +79.08% year-over-year, and up +1376.62% over the past 3 years
- All-Time High Comparison
- PEN TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- PEN TTM EBITDA is +537.20% above its 3-year low of $30.40M reached on an earlier date
- Sector Comparison
- PEN TTM EBITDA is higher than 86.36% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $193.73M | +6.5% | +79.1% | +1376.6% | +1657.7% | |
| Annual EBITDA | $45.99M | – | -57.7% | +486.7% | -17.3% | |
| Quarterly EBITDA | $51.33M | +10.8% | +29.9% | +340.2% | +405.2% | |
| Price | $316.15 | +26.9% | +25.3% | +37.2% | +61.9% | |
| PE Ratio | 75.55 | +26.9% | -89.7% | – | – | |
| TTM Revenue | $1.33B | +4.2% | +14.6% | +60.7% | +147.6% | |
| TTM EPS | $4.18 | +10.9% | +385.9% | +614.6% | +1619.9% | |
| TTM EBIT | $172.79M | +8.5% | +120.2% | +545.3% | +814.5% | |
| TTM Net Income | $164.03M | +11.1% | +374.8% | +637.6% | +1403.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $193.73M | at high | |
| 3Y | $193.73M | at high | |
| 5Y | $193.73M | at high | |
| All | $193.73M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $113.47M | N/A | +70.7% |
| 3Y | $30.40M | N/A | +537.2% |
| 5Y | -$23.55M | N/A | +922.6% |
| All | -$23.55M | +922.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of PEN?
As of today, PEN TTM EBITDA is $193.73M
What is PEN TTM EBITDA most recent change?
PEN TTM EBITDA was up +6.49% on September 30, 2025
What is 1-year change in PEN TTM EBITDA?
PEN TTM EBITDA is up +79.08% year-over-year
How far is PEN TTM EBITDA from its all-time high?
PEN TTM EBITDA is currently at its all-time high
How does PEN TTM EBITDA rank versus sector peers?
PEN TTM EBITDA is higher than 86.36% of companies in Healthcare sector
When is PEN next earnings release?
The next earnings release for PEN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- PEN Official Website www.penumbrainc.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1321732/000132173225000109/0001321732-25-000109-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1321732/000132173225000012/0001321732-25-000012-index.htm
- PEN Profile on Yahoo Finance finance.yahoo.com/quote/PEN
- PEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pen